P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer (Q39989754)

16 September 2017

P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer (English)

1 reference

16 September 2017

Costa A

1

1 reference

16 September 2017

Silvestrini R

2

1 reference

16 September 2017

Mochen C

3

1 reference

16 September 2017

Lequaglie C

4

1 reference

16 September 2017

Boracchi P

5

1 reference

16 September 2017

Faranda A

6

1 reference

16 September 2017

Vessecchia G

7

1 reference

16 September 2017

Ravasi G

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

British Journal of Cancer

16 September 2017

1 reference

16 September 2017

73

1 reference

16 September 2017

7

1 reference

16 September 2017

914-919

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.163

16 September 2017

0 references

cites work

Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

In vitro thymidine labelling of human pulmonary neoplasms

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

A new international staging system for lung cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

The relationship of p53 immunostaining to survival in carcinoma of the lung

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Accumulation of p53 protein correlates with a poor prognosis in human lung cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

p53 in non-small-cell lung cancer.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074267

Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer

20 August 2018

1 reference

12 December 2020

Prognostic significance of Ki67 labelling in resected non small cell lung cancer

1 reference

12 December 2020

Randomised clinical trial of adjuvant chemotherapy in patients with node-negative, fast-proliferating breast cancer

1 reference

12 December 2020

Clinical Relevance of Cell Kinetics in Breast Cancer

1 reference

12 December 2020

p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers

1 reference

12 December 2020

The role of surgery in N2 lung cancer

1 reference

12 December 2020

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer

1 reference

12 December 2020

Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer

1 reference

12 December 2020

Ki-67 immunostaining and survival in operable lung cancer

1 reference

12 December 2020

Autoradiographic and flow-cytometric assessment of cell proliferation in primary colorectal cancer: relationship to DNA ploidy and clinico-pathological features

1 reference

12 December 2020

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.163

1 reference

16 September 2017

1 reference

16 September 2017

PubMed publication ID

8611406

1 reference